Case report · 9 May 2025
EditorialPublished 10 Dec 2015
New Frontiers in Vitiligo Treatment: The Low Dose Cytokines-Based Therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Skin depigmentation phenomena, caused by the loss of melanocytes, are the distinctive feature of vitiligo. The inner mechanisms of melanocyte loss are still unclear; however, an increasing number of basic and clinical observations highlighted the fundamental role of cellular immunity, chronic inflammatory phenomena and intercellular cross-talk breakdown in vitiligo pathogenesis. The modulation of inflammatory phenomena and immune response and the restoration of keratinocytes-melanocytes axis with specific low dose SKA interleukins, antibodies and basic fibroblast growth factor represent an innovative therapeutic approach for vitiligo treatment based on Low Dose Medicine paradigm. Keywords: Vitiligo; Low dose medicine; Inflammation; Sequential kinetic activation; Interleukin 4; Interleukin 10; Anti-interleukin-1 antibodies; Basicfibroblast growth factor
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medical Case Reports.
Perspective · 5 Feb 2025
A Cancer Research Partnership Training Program Evaluation
Case report · 2025
A Rare Cause of Sepsis in a Patient with Chronic Kidney Disease-A Case Report
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Torello Lotti”

